Effectiveness of continuous positive airway pressure in lowering blood pressure in patients with obstructive sleep apnea: a critical review of the literature

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorFATURETO-BORGES, Fernanda
dc.contributor.authorLORENZI-FILHO, Geraldo
dc.contributor.authorDRAGER, Luciano F.
dc.date.accessioned2016-10-17T16:35:39Z
dc.date.available2016-10-17T16:35:39Z
dc.date.issued2016
dc.description.abstractObstructive sleep apnea (OSA) is an extremely common comorbid condition in patients with hypertension, with a prevalence of similar to 50%. There is growing evidence suggesting that OSA is a secondary cause of hypertension, associated with both poor blood pressure (BP) control and target organ damage in patients with hypertension. The application of continuous positive airway pressure (CPAP) during sleep is the gold standard treatment of moderate-to-severe OSA and very effective in abolishing obstructive respiratory events. However, several meta-analyses showed that the overall impact of CPAP on BP is modest (similar to 2 mmHg). There are several potential reasons for this disappointing finding, including the heterogeneity of patients studied (normotensive patients, controlled, and uncontrolled patients with hypertension), non-ideal CPAP compliance, clinical presentation (there is some evidence that the positive impact of CPAP on lowering BP is more evident in sleepy patients), and the multifactorial nature of hypertension. In this review, we performed a critical analysis of the literature evaluating the impact of CPAP on BP in several subgroups of patients. We finally discussed perspectives in this important research area, including the urgent need to identify predictors of BP response to CPAP and the importance of precision medicine in this scenario.
dc.description.indexPubMed
dc.identifier.citationINTEGRATED BLOOD PRESSURE CONTROL, v.9, p.43-47, 2016
dc.identifier.doi10.2147/IBPC.S70402
dc.identifier.issn1178-7104
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/16113
dc.language.isoeng
dc.publisherDOVE MEDICAL PRESS LTD
dc.relation.ispartofIntegrated Blood Pressure Control
dc.rightsopenAccess
dc.rights.holderCopyright DOVE MEDICAL PRESS LTD
dc.subjectcardiovascular disease
dc.subjectCPAP
dc.subjecthypertension
dc.subjectsleep apnea
dc.subjecttreatment
dc.subject.otherrandomized controlled-trial
dc.subject.otherplacebo-controlled trial
dc.subject.otherresistant hypertension
dc.subject.othermasked hypertension
dc.subject.othersystemic hypertension
dc.subject.otherarterial stiffness
dc.subject.otherclinical-trial
dc.subject.otherrisk
dc.subject.othercpap
dc.subject.otherbp
dc.subject.wosPeripheral Vascular Disease
dc.titleEffectiveness of continuous positive airway pressure in lowering blood pressure in patients with obstructive sleep apnea: a critical review of the literature
dc.typearticle
dc.type.categoryreview
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.citation.scopus31
hcfmusp.contributor.author-fmusphcFERNANDA FATURETO BORGES
hcfmusp.contributor.author-fmusphcGERALDO LORENZI FILHO
hcfmusp.contributor.author-fmusphcLUCIANO FERREIRA DRAGER
hcfmusp.description.beginpage43
hcfmusp.description.endpage47
hcfmusp.description.volume9
hcfmusp.origemWOS
hcfmusp.origem.pubmed27051313
hcfmusp.origem.scopus2-s2.0-84961857198
hcfmusp.origem.wosWOS:000382321600002
hcfmusp.publisher.cityALBANY
hcfmusp.publisher.countryNEW ZEALAND
hcfmusp.relation.referenceAncoli-Israel S, 2002, CHEST, V122, P1148, DOI 10.1378/chest.122.4.1148
hcfmusp.relation.referenceBagueta JP, 2008, J HYPERTENS, V26, P885, DOI 10.1097/HJH.0b013e3282f55049
hcfmusp.relation.referenceBarbe F, 2010, AM J RESP CRIT CARE, V181, P718, DOI 10.1164/rccm.200901-0050OC
hcfmusp.relation.referenceBazzano LA, 2007, HYPERTENSION, V50, P417, DOI 10.1161/HYPERTENSIONAHA.106.085175
hcfmusp.relation.referenceBratton DJ, 2014, THORAX, V69, P1128, DOI 10.1136/thoraxjnl-2013-204993
hcfmusp.relation.referenceCampos-Rodriguez F, 2006, CHEST, V129, P1459, DOI 10.1378/chest.129.6.1459
hcfmusp.relation.referenceCosta LE, 2015, HEART, V101, P1288, DOI 10.1136/heartjnl-2014-307276
hcfmusp.relation.referencede Oliveira AC, 2014, AM J RESP CRIT CARE, V190, P345, DOI 10.1164/rccm.201403-0479LE
hcfmusp.relation.referenceDrager LF, 2007, AM J RESP CRIT CARE, V176, P706, DOI 10.1164/rccm.200703-500OC
hcfmusp.relation.referenceDrager LF, 2010, AM J HYPERTENS, V23, P249, DOI 10.1038/ajh.2009.246
hcfmusp.relation.referenceDrager LF, 2007, CHEST, V131, P1379, DOI 10.1378/chest.06-2703
hcfmusp.relation.referenceDrager LF, 2011, HYPERTENSION, V57, P549, DOI 10.1161/HYPERTENSIONAHA.110.165969
hcfmusp.relation.referenceDrager LF, 2010, AM J CARDIOL, V105, P1135, DOI 10.1016/j.amjcard.2009.12.017
hcfmusp.relation.referenceDrager LF, 2013, J AM COLL CARDIOL, V62, P569, DOI 10.1016/j.jacc.2013.05.045
hcfmusp.relation.referenceDuran-Cantolla J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5991
hcfmusp.relation.referenceFaccenda JF, 2001, AM J RESP CRIT CARE, V163, P344
hcfmusp.relation.referenceFava C, 2014, CHEST, V145, P762, DOI 10.1378/chest.13-1115
hcfmusp.relation.referenceFlemons WW, 1999, SLEEP, V22, P667
hcfmusp.relation.referenceFurlan SF, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0663-z
hcfmusp.relation.referenceHaentjens P, 2007, ARCH INTERN MED, V167, P757, DOI 10.1001/archinte.167.8.757
hcfmusp.relation.referenceHuang ZW, 2015, AM J HYPERTENS, V28, P300, DOI 10.1093/ajh/hpu147
hcfmusp.relation.referenceLitvin A Y, 2013, Vasc Health Risk Manag, V9, P229, DOI 10.2147/VHRM.S40231
hcfmusp.relation.referenceLiu L, J CLIN HYPERTENS GRE
hcfmusp.relation.referenceLogan AG, 2003, EUR RESPIR J, V21, P241, DOI 10.1183/09031936.03.00035402
hcfmusp.relation.referenceLogan AG, 2001, J HYPERTENS, V19, P2271, DOI 10.1097/00004872-200112000-00022
hcfmusp.relation.referenceLozano L, 2010, J HYPERTENS, V28, P2161, DOI 10.1097/HJH.0b013e32833b9c63
hcfmusp.relation.referenceMarin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7
hcfmusp.relation.referenceMarin JM, 2012, JAMA-J AM MED ASSOC, V307, P2169, DOI 10.1001/jama.2012.3418
hcfmusp.relation.referenceMartinez-Garcia MA, 2013, JAMA-J AM MED ASSOC, V310, P2407, DOI 10.1001/jama.2013.281250
hcfmusp.relation.referenceMuxfeldt ES, 2015, HYPERTENSION, V65, P736, DOI 10.1161/HYPERTENSIONAHA.114.04852
hcfmusp.relation.referenceNguyen PK, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-50
hcfmusp.relation.referencePedrosa RP, 2011, HYPERTENSION, V58, P811, DOI 10.1161/HYPERTENSIONAHA.111.179788
hcfmusp.relation.referencePedrosa RP, 2013, CHEST, V144, P1487, DOI 10.1378/chest.13-0085
hcfmusp.relation.referencePepin JL, 2010, AM J RESP CRIT CARE, V182, P954, DOI 10.1164/rccm.200912-1803OC
hcfmusp.relation.referencePeppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342
hcfmusp.relation.referencePickering TG, 2007, HYPERTENS RES, V30, P479, DOI 10.1291/hypres.30.479
hcfmusp.relation.referenceRobinson GV, 2006, EUR RESPIR J, V27, P1229, DOI 10.1183/09031936.06.00062805
hcfmusp.relation.referenceSanchez-de-la-Torre M, 2015, J AM COLL CARDIOL, V66, P1023, DOI 10.1016/j.jacc.2015.06.1315
hcfmusp.relation.referenceTurnbull F, 2003, LANCET, V362, P1527
hcfmusp.relation.referenceVasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417
hcfmusp.relation.referenceYorgun H, 2014, ANGIOLOGY, V65, P98, DOI 10.1177/0003319713477908
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublication28ec6bce-34c6-4f40-8b9d-5e589c621b17
relation.isAuthorOfPublication50462524-ec24-4cf2-9c62-67193479cd0c
relation.isAuthorOfPublication45056c2e-919d-4fc1-97d3-356e54fe3385
relation.isAuthorOfPublication.latestForDiscovery45056c2e-919d-4fc1-97d3-356e54fe3385
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
art_FATURETO-BORGES_Effectiveness_of_continuous_positive_airway_pressure_in_lowering_2016.PDF
Tamanho:
231.75 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)